Oral Micronized Progesterone Cost in Tennessee (2026)

What Does Oral Micronized Progesterone Actually Cost in Tennessee?

The price you pay depends on whether you fill brand Prometrium, a generic equivalent, or a compounded formulation. Brand Prometrium carries a manufacturer list price of roughly $180 per month for a 30-capsule supply of 200 mg capsules. Generic OMP, which contains the same FDA-approved micronized progesterone formulation, averages $45 per month across Tennessee retail pharmacies in 2026.

Compounded progesterone from a licensed 503A pharmacy in Tennessee costs approximately $25 per month. That price gap matters. A patient paying cash for brand Prometrium over 12 months spends $2,160, while the same patient using compounded progesterone spends $300. The FDA does not verify compounded products for bioequivalence, a distinction the Endocrine Society's 2015 guideline on menopausal hormone therapy flags as clinically relevant when selecting a progesterone source.

Tennessee ranks in the middle third of U.S. states for OMP pricing. Pharmacy markup varies by region. Memphis and Nashville metro pharmacies tend to cluster near the $45 average, while rural East Tennessee pharmacies may charge $50 to $60 for the same generic product without a discount card. Warehouse pharmacies (Costco, Sam's Club) in Knoxville and Chattanooga often price generic OMP between $30 and $38 per month, even without a membership for pharmacy-only access, which Tennessee law permits per state board of pharmacy regulations.

Does Tennessee Medicaid (TennCare) Cover OMP?

TennCare does not cover oral micronized progesterone for endometrial protection in women on estrogen replacement therapy. The program restricts progesterone coverage to type 2 diabetes-related indications only. This leaves TennCare enrollees who need endometrial protection during HRT without a covered option for OMP through the state Medicaid formulary.

This gap is significant given the clinical evidence. The landmark PEPI trial (N=875) demonstrated that micronized progesterone provided equivalent endometrial protection to medroxyprogesterone acetate (MPA) while producing a more favorable lipid profile. Specifically, OMP preserved the HDL-cholesterol benefit of conjugated equine estrogens, while MPA partially blunted that benefit. The Women's Health Initiative observational data later reinforced that progesterone type matters for cardiovascular and breast cancer risk profiles.

TennCare enrollees have limited workarounds. A prescriber can submit a prior authorization request citing medical necessity, though approval rates for off-formulary HRT components remain low. Alternatively, the $25 per month compounded option or a manufacturer savings card applied to a brand prescription may bring costs below what a TennCare copay would have been. The ACOG Practice Bulletin on HRT (2021) recommends progesterone co-administration for any woman with an intact uterus taking systemic estrogen, a standard of care that TennCare's formulary restriction effectively undermines for its enrollees.

Insurance Coverage for OMP Across Tennessee

Most commercial insurance plans available in Tennessee cover generic oral micronized progesterone on their formulary, typically placing it at Tier 1 or Tier 2. Copays generally range from $10 to $35 per month depending on the plan. BlueCross BlueShield of Tennessee, the state's largest insurer, lists generic progesterone on its preferred drug list for 2026.

Brand Prometrium often sits at Tier 3, carrying copays of $40 to $75 or requiring step therapy through a generic first. Patients whose prescribers write "dispense as written" for Prometrium should expect higher out-of-pocket costs unless the plan has no generic-first requirement.

For patients on Medicare Part D plans in Tennessee, generic OMP is widely covered. During the initial coverage phase, copays typically fall between $5 and $20. After the Inflation Reduction Act's $2,000 annual out-of-pocket cap took full effect in 2025, OMP costs for Medicare beneficiaries became more predictable. The NAMS 2022 position statement on hormone therapy notes that micronized progesterone is the preferred progestogen for most menopausal women, a recommendation that supports formulary inclusion arguments during appeals.

Marketplace (ACA) plans sold on the Tennessee exchange vary more widely. Ambetter, Oscar, and Cigna plans sold in Nashville and Memphis metro areas cover generic OMP, but rural-only plan options may have narrower formularies. Checking the specific plan's drug list before open enrollment prevents surprises at the pharmacy counter.

Compounded Progesterone in Tennessee: Legal Status and Considerations

Compounded progesterone is legal in Tennessee through licensed 503A pharmacies operating under state board of pharmacy oversight. These pharmacies prepare individualized prescriptions based on a prescriber's order. Tennessee does not restrict 503A compounding of bioidentical hormones, and several compounding pharmacies operate in Nashville, Memphis, Knoxville, and Chattanooga.

The cost advantage is clear: $25 per month versus $45 for generic or $180 for brand. Some compounding pharmacies offer 90-day supplies at further discount, bringing per-month cost to $20 or less.

The clinical tradeoff requires consideration. The FDA's 2020 advisory committee review emphasized that compounded hormones are not FDA-approved, not tested for bioequivalence, and not subject to the same manufacturing standards as commercial products. Potency variability between batches has been documented. A 2001 FDA survey of compounded hormone products found that 34% of tested samples failed potency specifications. The Endocrine Society and ACOG both recommend FDA-approved formulations over compounded alternatives when an approved product exists at a manageable price.

For patients choosing compounded progesterone in Tennessee, verifying the pharmacy's accreditation through the Pharmacy Compounding Accreditation Board (PCAB) provides one layer of quality assurance. Asking the pharmacy for recent third-party potency testing results is a reasonable additional step.

Telehealth Access to OMP in Tennessee

Tennessee permits telehealth prescribing of oral micronized progesterone. No in-person visit is required for an initial prescription. The state's telehealth parity law, updated in 2023, requires insurers to cover telehealth visits at the same rate as in-person encounters.

This matters for OMP access because many Tennessee counties lack an endocrinologist or menopause-trained gynecologist. Forty-five of Tennessee's 95 counties are classified as Health Professional Shortage Areas for primary care. Telehealth platforms that specialize in HRT (including HealthRX) can connect patients in rural Tennessee with prescribers experienced in menopausal hormone management.

A telehealth visit for HRT typically costs $75 to $150 for an initial consultation, with follow-ups at $50 to $100. Many commercial insurance plans cover these visits with a standard specialist copay. The prescription itself can be sent electronically to any Tennessee pharmacy, including compounding pharmacies that accept e-prescriptions. The North American Menopause Society (NAMS) supports telehealth as an appropriate modality for initiating and managing menopausal hormone therapy in established patients.

How to Get the Lowest Price on OMP in Tennessee

Several strategies can reduce out-of-pocket costs below the $45 average.

Discount card programs. GoodRx, RxSaver, and SingleCare consistently show generic OMP at $15 to $28 per month at major Tennessee chain pharmacies. These prices apply regardless of insurance status. Walmart and Kroger (Tennessee's two largest pharmacy chains by location count) often have the lowest discount-card prices.

Manufacturer savings cards. The Prometrium savings card, offered through Solvay/AbbVie, can reduce brand copays to as low as $25 per month for commercially insured patients. The card does not apply to government insurance (Medicaid, Medicare, Tricare). Eligibility and maximum annual benefit vary by program year. Patients can check current terms at the Prometrium prescribing information and savings page.

90-day fills. Most Tennessee pharmacies and mail-order services offer 90-day supplies at a 10% to 20% discount per unit compared to 30-day fills. For a patient paying $45 per month, a 90-day fill might cost $115 to $120 instead of $135.

Compounding. As noted, $25 per month from a licensed 503A pharmacy represents the floor price in Tennessee, with some pharmacies offering $20 per month on 90-day supplies.

Patient assistance programs. AbbVie's patient assistance program provides brand Prometrium at no cost to uninsured patients meeting income requirements (typically at or below 200% of the federal poverty level). Applications require prescriber involvement and proof of income. The NeedyMeds database tracks current eligibility criteria.

Clinical Context: Why OMP Over Synthetic Progestins?

The preference for micronized progesterone over synthetic progestins like medroxyprogesterone acetate (MPA) stems from safety data accumulated over two decades. The E3N French cohort study (N=80,377) found that estrogen combined with micronized progesterone did not increase breast cancer risk over a mean follow-up of 8.1 years, while estrogen plus synthetic progestins carried a statistically significant increased risk (RR 1.69 to 95% CI 1.50 to 1.91).

The KEEPS trial (N=727) provided additional reassurance, showing that oral conjugated equine estrogens plus cyclic micronized progesterone (200 mg for 12 days per month) did not worsen carotid intima-media thickness or coronary artery calcium scores over four years in recently menopausal women. These findings informed the 2022 NAMS position statement, which identifies micronized progesterone as the preferred progestogen when breast cancer risk is a concern.

Sleep quality represents a secondary benefit. Progesterone's metabolite, allopregnanolone, acts on GABA-A receptors. A 2018 systematic review found that oral micronized progesterone improved subjective sleep quality in menopausal women compared to placebo. This effect is specific to the oral route. Vaginal progesterone does not produce clinically meaningful allopregnanolone levels.

Dosing in Tennessee follows national standards: 200 mg nightly for continuous regimens or 200 mg on days 1 through 12 of each calendar month for cyclic regimens. The ACOG practice bulletin recommends a minimum of 12 days of progesterone exposure per cycle for adequate endometrial protection. Prescribers adjusting the dose should verify that serum progesterone levels reach the 4 to 8 ng/mL trough range associated with endometrial suppression.

Choosing Between Brand, Generic, and Compounded in Tennessee

The decision tree is straightforward. If commercial insurance covers generic OMP with a low copay ($10 to $20), fill the generic. If uninsured or underinsured, a discount card brings generic to $15 to $28 at most Tennessee pharmacies. If even that price point is a barrier, compounded progesterone at $25 per month (or less on 90-day supply) is available from licensed 503A pharmacies across the state.

Brand Prometrium makes financial sense only when a manufacturer savings card reduces the copay below what generic would cost, a rare scenario but possible for patients on high-deductible plans who haven't met their deductible. The FDA's Orange Book confirms that all approved generic OMP products have demonstrated bioequivalence to Prometrium, so therapeutic substitution carries no expected clinical difference.

One clinical note: OMP capsules contain peanut oil as the suspension vehicle. Patients with peanut allergy should use a compounded formulation prepared in an alternative oil base (olive oil or sunflower oil are common substitutes) or discuss vaginal progesterone alternatives with their prescriber. The Prometrium prescribing label carries a specific warning about peanut allergy.

Tennessee patients filling OMP at 200 mg nightly should expect their prescriber to order baseline and annual endometrial thickness monitoring via transvaginal ultrasound, along with lipid panels at 3 and 12 months after initiation, per Endocrine Society clinical practice guidelines.